Evidence map›Paper›PMID 21193749›Full record

ArticleStroke2011

Pharmacologically augmented S-nitrosylated hemoglobin improves recovery from murine subarachnoid hemorrhage.

Huaxin Sheng, James D Reynolds, Richard L Auten, Ivan T Demchenko, Claude A Piantadosi, Jonathan S Stamler, David S Warner

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Stroke, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Review
  7. Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Review
  8. Article
  9. Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
  10. Article
  11. Review
  12. Article
  13. Protein Oxidative Modifications: Beneficial Roles in Disease and Health.Journal of biochemical and pharmacological research · 2013
    Article
  14. Review
  15. Review
  16. Nitric oxide: considerations for the treatment of ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2012
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huaxin ShengDepartment of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
James D Reynolds
Richard L Auten
Ivan T Demchenko
Claude A Piantadosi
Jonathan S Stamler
David S Warner
Duke University · US

Funding

Red Blood Cell S-nitrosothiols and OxygenationR01HL091876 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2009 to 2012
$1.6M
Restoration and Function of S-nitrosothiol in Stored BloodR01HL095463 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI STAMLER, JONATHAN S. · 2009 to 2012
$1.5M
S-Nitrosylated Hemoglobin and Ischemic Brain InjuryR21NS063108 · NINDS · DUKE UNIVERSITY · PI WARNER, DAVID · 2009 to 2010
$429k
Ethyl Nitrite and Subarachnoid HemorrhageR21NS058321 · NINDS · DUKE UNIVERSITY · PI SHENG, HUAXIN · 2008 to 2009
$375k
NHLBI NIH HHS 1R01HL091876NHLBI NIH HHS 1R01HL095463NHLBI NIH HHS R01 HL091876NHLBI NIH HHS R01 HL095463NINDS NIH HHS 5R21NS058321NINDS NIH HHS R21 NS058321NINDS NIH HHS R21 NS063108PHS HHS 5R21N3063108
6 · The paper itself

Abstract

background and purposeS-nitrosylated hemoglobin (S-nitrosohemoglobin) has been implicated in the delivery of O(2) to tissues through the regulation of microvascular blood flow. This study tested the hypothesis that enhancement of S-nitrosylated hemoglobin by ethyl nitrite inhalation improves outcome after experimental subarachnoid hemorrhage (SAH).

methodsA preliminary dosing study identified 20 ppm ethyl nitrite as a concentration that produced a 4-fold increase in S-nitrosylated hemoglobin concentration with no increase in methemoglobin. Mice were subjected to endovascular perforation of the right anterior cerebral artery and were treated with 20 ppm ethyl nitrite in air, or air alone for 72 hours, after which neurologic function, cerebral vessel diameter, brain water content, cortical tissue Po(2), and parenchymal red blood cell flow velocity were measured.

resultsAt 72 hours after hemorrhage, air- and ethyl nitrite-exposed mice had similarly sized blood clots. Ethyl nitrite improved neurologic score and rotarod performance; abated SAH-induced constrictions in the ipsilateral anterior, middle cerebral, and internal carotid arteries; and prevented an increase in ipsilateral brain water content. Ethyl nitrite inhalation increased red blood cell flow velocity and cortical tissue Po(2) in the ipsilateral cortex with no effect on systemic blood pressure.

conclusionsTargeted S-nitrosylation of hemoglobin improved outcome parameters, including vessel diameter, tissue blood flow, cortical tissue Po(2), and neurologic function in a murine SAH model. Augmenting endogenous Po(2)-dependent delivery of NO bioactivity to selectively dilate the compromised cerebral vasculature has significant clinical potential in the treatment of SAH.

Indexed as

Adjuvants, PharmaceuticAdministration, InhalationAnimalsDrug SynergismHemoglobinsMaleMiceMice, Inbred C57BLNitritesRecovery of FunctionSubarachnoid HemorrhageAdjuvants, Pharmaceuticethyl nitriteHemoglobinsNitritesS-nitrosohemoglobin

Identifiers

PMID21193749
PMCPMC3575516
OpenAlexW2059888599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.